Appointment of Independent Non-Executive Director
08/03/2022 10:30
For best results when printing this announcement, please click on link below:
http://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20220308:nRSH0221Ea&default-theme=true
RNS Number : 0221E Tintra PLC 08 March 2022
THIS ANNOUNCEMENT CONTAINS INSIDE INFORMATION FOR THE PURPOSES OF REGULATION
11 OF THE MARKET ABUSE (AMENDMENT) (EU EXIT) REGULATIONS 2019/310.
8 March 2022
TINTRA PLC
("Tintra", the "Group" or the "Company")
Appointment of Independent Non-Executive Director
The Board is pleased to announce the appointment yesterday of Dr Andrew
Bowen as an Independent Non-Executive Director for the next stage of the
Group's progress.
Dr Bowen is the Managing Director of his own advisory firm, a Senior
Counsellor to Palantir Technologies and an investment advisor to several
prominent family offices in the US, Europe, and the Middle East. In addition,
he is a member of the investment team of MD1, a venture capital fund focused
on national security innovation.
Andrew has held research fellowships at the American Enterprise Institute, the
Wilson Center, the Center for National Interest, and the James A. Baker III
Institute for Public Policy at Rice University. His research and writings have
focused on geopolitics, geo-economics, and international history.
Andrew received a Ph.D. in International Relations and an M.Sc. in
International History from the London School Economics, as well as a B.A. in
Political Science from Rice University.
Dr Bowen said, "We often discuss these days Web 3.0 and the rise of this
post-modern metaverse but often forget that a super majority of the world's
population still can't transact with one another on the most basic of
transactions. These barriers and the costs associated with them have yet to be
broken and Tintra is one of the few technology companies seeking to break that
last ceiling in global finance. As resurgent nationalism is dividing the world
presently, there are opportunities to still make the global economy more
connected and efficient. Tintra has brought together a strong team of
technologists and financial services veterans to disrupt finance sensibly and
sustainably."
Richard Shearer, Tintra's CEO, said, "Whilst we are first and foremost a tech
company building the world's first Web 3.0 Bank using artificial intelligence
driven RegTech, a large point of our differentiation as we build out our model
is the geo-political and geo-fiscal landscape that sits at the heart of the
cross-border issues we discuss, which are often neglected as part of the macro
discussion.
To build an AI engine that truly solves the issues rather than simply pays lip
service to them, we need to think differently. And we very much do.
It is precisely to that end that Dr Bowen's addition gives us even deeper
in-house geopolitical thinking and an exceptionally experienced international
relations mind as we navigate regional governments, regulators and cultures.
I'm delighted to welcome Andrew to our Board. His certainty in the need for
our model in the marketplace, and Tintra's ability to execute on it, is
something I find extremely encouraging and I very much look forward to working
with him and drawing on his vast experience."
Regulatory disclosures
In accordance with Schedule 2(g) of the AIM Rules, Dr Andrew James Bowen
(aged 36) holds, or has held in the past 5 years, the following directorships
and partnerships:
Current Past five years
Achria Capital LLC (Delaware, USA) N/A
Dr Bowen has no current interest in the ordinary share capital of the
Company.
For further information, contact:
Tintra PLC 020 3795 0421
(Communications Head)
Hannah Haffield
h.haffield@tintra.com
Website www.tintra.com
Allenby Capital Limited 020 3328 5656
(Nomad, Financial Adviser & Broker)
John Depasquale / Nick Harriss / Vivek Bhardwaj
This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
or visit
www.rns.com (http://www.rns.com/)
.
RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
. END BOAEAEDPEFKAEFA